Newsletter

Made In Thailand – 4 Covid-19 vaccines, Thai nationality, waiting for FDA registration Which one is there? Check it out here!!

Made In Thailand, we also have good in Thailand – another work of Thai people 4 Covid-19 vaccine, Thai nationality Waiting for FDA registration Which one is there? Check it out here!!

In the situation of the spread of COVID-19 Thailand has imported medicines. and the COVID-19 vaccine from abroad for the people in the country for many brands A total of six vaccines are currently registered with the Food and Drug Administration, namely AstraZeneca, Sinovac, Pfizer, Moderna, Johnson & Johnson and Sinofarm. There are also other national vaccines that are in the process of applying for future registration.

But in Thailand, we are not inferior to others. By on March 28, 2022 on the Facebook page Thailand knows how to fight covid Revealing the progress in research and development of the COVID-19 vaccine in Thailand, there are currently more than 20 types of vaccines under research and development, of which the 4 most advanced vaccines are Chula-Cov19 vaccine, HXP-GPOVac vaccine. Baiya SARS-CoV-2 Vax Covigen vaccine currently in human testing. and if the test completes three phases will be able to apply for registration with the Food and Drug Administration (FDA).

for other vaccines Progress has been made in animal testing. and there are many types including viral vector, protein subunit, mRNA, virus-like particle (VLP), etc., which advances in vaccine development It comes from the full cooperation of many sectors. Both government agencies such as the National Vaccine Institute Pharmaceutical Organization, NSTDA by the National Center for Genetic Engineering and Biotechnology (Biotech), higher education institutions such as Chulalongkorn University Mahidol University and the private sector, etc.

for the development of the nasal spray COVID-19 vaccine, which is likely to be used more The advantage is easy to use. It is a vaccine administered by aerosol in the nasal cavity through a special syringe designed to deliver the vaccine directly to the immune system in the mucous membranes of the upper respiratory tract. The virus most often enters the body through the nose and forms in the nasal cavity before spreading to other parts of the body. of the body, including the lungs which is now a team of biotech researchers Has developed a nasal spray vaccine “NASTVAC” that has been tested on animals. Approximately 200-300 doses of vaccine samples are expected to be available for human testing in the second quarter of this year. There is also a nasal spray antibody that has anti-COVID-19 properties.

Trending